CovidChloroV1, Main, Exploration, bibRecord, 000857

Repurposing antimalarials and other drugs for COVID-19.

Identifieur interne : 000857 ( Main/Exploration ); précédent : 000856; suivant : 000858

Repurposing antimalarials and other drugs for COVID-19.

Auteurs : Patricia Schlagenhauf [Suisse] ; Martin P. Grobusch [Pays-Bas] ; Julian D. Maier [Suisse] ; Philippe Gautret [France]

Source :

Travel medicine and infectious disease [ 1873-0442 ]

RBID : pubmed:32247925

Descripteurs français

KwdFr :
- AMP (analogues et dérivés), AMP (usage thérapeutique), Alanine (analogues et dérivés), Alanine (usage thérapeutique), Antipaludiques (usage thérapeutique), Antiviraux (usage thérapeutique), Betacoronavirus (MeSH), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Infections à coronavirus (traitement médicamenteux), Pandémies (MeSH), Pneumopathie virale (traitement médicamenteux), Repositionnement des médicaments (MeSH).
MESH :
- analogues et dérivés : AMP, Alanine.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : AMP, Alanine, Antipaludiques, Antiviraux, Hydroxychloroquine.
- Betacoronavirus, Humains, Pandémies, Repositionnement des médicaments.

English descriptors

KwdEn :
- Adenosine Monophosphate (analogs & derivatives), Adenosine Monophosphate (therapeutic use), Alanine (analogs & derivatives), Alanine (therapeutic use), Antimalarials (therapeutic use), Antiviral Agents (therapeutic use), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Drug Repositioning (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), SARS-CoV-2 (MeSH).
MESH :
- chemical , analogs & derivatives : Adenosine Monophosphate, Alanine.
- chemical , therapeutic use : Adenosine Monophosphate, Alanine, Antimalarials, Antiviral Agents, Hydroxychloroquine.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, COVID-19, Drug Repositioning, Humans, Pandemics, SARS-CoV-2.

DOI: 10.1016/j.tmaid.2020.101658
PubMed: 32247925
PubMed Central: PMC7194516

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001A28
to stream Main, to step Curation: 001A28

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Repurposing antimalarials and other drugs for COVID-19.</title>
<author><name sortKey="Schlagenhauf, Patricia" sort="Schlagenhauf, Patricia" uniqKey="Schlagenhauf P" first="Patricia" last="Schlagenhauf">Patricia Schlagenhauf</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich, Switzerland. Electronic address: patricia.schlagenhauf@uzh.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grobusch, Martin P" sort="Grobusch, Martin P" uniqKey="Grobusch M" first="Martin P" last="Grobusch">Martin P. Grobusch</name>
<affiliation wicri:level="3"><nlm:affiliation>Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maier, Julian D" sort="Maier, Julian D" uniqKey="Maier J" first="Julian D" last="Maier">Julian D. Maier</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gautret, Philippe" sort="Gautret, Philippe" uniqKey="Gautret P" first="Philippe" last="Gautret">Philippe Gautret</name>
<affiliation wicri:level="3"><nlm:affiliation>Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Mar - Apr</date>
<idno type="RBID">pubmed:32247925</idno>
<idno type="pmid">32247925</idno>
<idno type="doi">10.1016/j.tmaid.2020.101658</idno>
<idno type="pmc">PMC7194516</idno>
<idno type="wicri:Area/Main/Corpus">001A28</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001A28</idno>
<idno type="wicri:Area/Main/Curation">001A28</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001A28</idno>
<idno type="wicri:Area/Main/Exploration">001A28</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Repurposing antimalarials and other drugs for COVID-19.</title>
<author><name sortKey="Schlagenhauf, Patricia" sort="Schlagenhauf, Patricia" uniqKey="Schlagenhauf P" first="Patricia" last="Schlagenhauf">Patricia Schlagenhauf</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich, Switzerland. Electronic address: patricia.schlagenhauf@uzh.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grobusch, Martin P" sort="Grobusch, Martin P" uniqKey="Grobusch M" first="Martin P" last="Grobusch">Martin P. Grobusch</name>
<affiliation wicri:level="3"><nlm:affiliation>Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maier, Julian D" sort="Maier, Julian D" uniqKey="Maier J" first="Julian D" last="Maier">Julian D. Maier</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich</wicri:regionArea>
<wicri:noRegion>Zurich</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gautret, Philippe" sort="Gautret, Philippe" uniqKey="Gautret P" first="Philippe" last="Gautret">Philippe Gautret</name>
<affiliation wicri:level="3"><nlm:affiliation>Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Travel medicine and infectious disease</title>
<idno type="eISSN">1873-0442</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Drug Repositioning (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>AMP (analogues et dérivés)</term>
<term>AMP (usage thérapeutique)</term>
<term>Alanine (analogues et dérivés)</term>
<term>Alanine (usage thérapeutique)</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Repositionnement des médicaments (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Antimalarials</term>
<term>Antiviral Agents</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
<term>Antipaludiques</term>
<term>Antiviraux</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Drug Repositioning</term>
<term>Humans</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term>
<term>Humains</term>
<term>Pandémies</term>
<term>Repositionnement des médicaments</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32247925</PMID>
<DateCompleted><Year>2020</Year>
<Month>05</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0442</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>34</Volume>
<PubDate><MedlineDate>2020 Mar - Apr</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Travel medicine and infectious disease</Title>
<ISOAbbreviation>Travel Med Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Repurposing antimalarials and other drugs for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>101658</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1477-8939(20)30126-5</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmaid.2020.101658</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schlagenhauf</LastName>
<ForeName>Patricia</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich, Switzerland. Electronic address: patricia.schlagenhauf@uzh.ch.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grobusch</LastName>
<ForeName>Martin P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo><Affiliation>Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Maier</LastName>
<ForeName>Julian D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo><Affiliation>University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gautret</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Travel Med Infect Dis</MedlineTA>
<NlmUniqueID>101230758</NlmUniqueID>
<ISSNLinking>1477-8939</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058492" MajorTopicYN="Y">Drug Repositioning</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32247925</ArticleId>
<ArticleId IdType="pii">S1477-8939(20)30126-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.tmaid.2020.101658</ArticleId>
<ArticleId IdType="pmc">PMC7194516</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>BMJ. 2003 Nov 8;327(7423):1078</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14604928</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar 20;:105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Mar 09;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Mar 17;368:m1066</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32184233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101615</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32145386</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):970-971</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32003551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2019 Jul - Aug;30:9-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31252170</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
<li>Pays-Bas</li>
<li>Suisse</li>
</country>
<region><li>Hollande-Septentrionale</li>
<li>Provence-Alpes-Côte d'Azur</li>
</region>
<settlement><li>Amsterdam</li>
<li>Marseille</li>
</settlement>
</list>
<tree><country name="Suisse"><noRegion><name sortKey="Schlagenhauf, Patricia" sort="Schlagenhauf, Patricia" uniqKey="Schlagenhauf P" first="Patricia" last="Schlagenhauf">Patricia Schlagenhauf</name>
</noRegion>
<name sortKey="Maier, Julian D" sort="Maier, Julian D" uniqKey="Maier J" first="Julian D" last="Maier">Julian D. Maier</name>
</country>
<country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Grobusch, Martin P" sort="Grobusch, Martin P" uniqKey="Grobusch M" first="Martin P" last="Grobusch">Martin P. Grobusch</name>
</region>
</country>
<country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Gautret, Philippe" sort="Gautret, Philippe" uniqKey="Gautret P" first="Philippe" last="Gautret">Philippe Gautret</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000857 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000857 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32247925
   |texte=   Repurposing antimalarials and other drugs for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32247925" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Repurposing antimalarials and other drugs for COVID-19.

Repurposing antimalarials and other drugs for COVID-19.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki